Literature DB >> 8962350

Impairment of DNA repair in the course of long-term hemodialysis and under cyclosporine immunosuppression after renal transplantation.

S Vamvakas1, U Bahner, P Becker, A Steinle, R Götz, A Heidland.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8962350

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  9 in total

1.  Calcineurin inhibitors reduce nuclear localization of transcription factor NFAT in UV-irradiated keratinocytes and reduce DNA repair.

Authors:  Matthew T Canning; Stephanie L Nay; Arely V Peña; Daniel B Yarosh
Journal:  J Mol Histol       Date:  2006-08-23       Impact factor: 2.611

2.  Cancer risk in patients receiving renal replacement therapy: A meta-analysis of cohort studies.

Authors:  Weifeng Shang; Liu Huang; Li Li; Xiaojuan Li; Rui Zeng; Shuwang Ge; Gang Xu
Journal:  Mol Clin Oncol       Date:  2016-07-07

3.  Prevention of DNA damage in renal transplantation by losartan and enalapril: the role of renin-angiotensin system polymorphisms.

Authors:  Amir Ghorbanihaghjo; Pegah Veisi; Hassan Argani; Mohammad Aghaeishahsavari; Masood Noroozianavval; Nadereh Rashtchizadeh; Mehran Mesgari; Javid Safa; Hosain Babaei
Journal:  Clin Exp Nephrol       Date:  2008-01-05       Impact factor: 2.801

Review 4.  Genomic damage in endstage renal disease-contribution of uremic toxins.

Authors:  Nicole Schupp; August Heidland; Helga Stopper
Journal:  Toxins (Basel)       Date:  2010-10-11       Impact factor: 4.546

5.  Using the cytokinesis-block micronucleus cytome assay to evaluate chromosomal DNA damage in chronic renal patients undergoing bicarbonate haemodialysis and haemodiafiltration.

Authors:  M Guido; A Zizza; M R Tumolo; G Stefanelli; M D'Alba; A Idolo; F Bagordo; F Serio; T Grassi; A DE Donno
Journal:  J Prev Med Hyg       Date:  2016-09

6.  Cancer in Korean patients with end-stage renal disease: A 7-year follow-up.

Authors:  Kyung Don Yoo; Jung Pyo Lee; Su Mi Lee; Jae Yoon Park; Hajeong Lee; Dong Ki Kim; Shin-Wook Kang; Chul Woo Yang; Yong-Lim Kim; Chun Soo Lim; Kwon Wook Joo; Yon Su Kim
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

7.  Is there different risk of cancer among end-stage renal disease patients undergoing hemodialysis and peritoneal dialysis?

Authors:  Yi-Che Lee; Shih-Yuan Hung; Hao-Kuang Wang; Chi-Wei Lin; Hsi-Hao Wang; Min-Yu Chang; Junne-Ming Sung; Yuan-Yow Chiou; Sheng-Hsiang Lin
Journal:  Cancer Med       Date:  2018-01-22       Impact factor: 4.452

8.  Genetic damage in patients with chronic kidney disease, peritoneal dialysis and haemodialysis: a comparative study.

Authors:  Angélica Rangel-López; Maria Eugenia Paniagua-Medina; Marcia Urbán-Reyes; Martha Cortes-Arredondo; Cleto Alvarez-Aguilar; Joel López-Meza; Alejandra Ochoa-Zarzosa; Bengt Lindholm; Elvia García-López; José Ramón Paniagua
Journal:  Mutagenesis       Date:  2013-03       Impact factor: 3.000

Review 9.  DNA Damage in Chronic Kidney Disease: Evaluation of Clinical Biomarkers.

Authors:  Nicole Schupp; Helga Stopper; August Heidland
Journal:  Oxid Med Cell Longev       Date:  2016-05-25       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.